Forgot your password?
The awards took place at the Reading office of our sponsor, Sanofi Genzyme, and were presented by Dr Hilary Jones.
OBE awarded for his services to the national COVID-19 response
The guideline is the first from NICE to recommend mental health support for people with acne experiencing psychological distress
Positive CHMP opinion is based on results from three Phase III studies – BE VIVID, BE READY and BE SURE
Libtayo becomes the first immunotherapy indicated for patients with advanced basal cell carcinoma
In the Phase IIIb COSMOS study, guselkumab helped patients to achieve complete skin clearance
Interleukin-23 inhibitor recommended for patients with moderate-to-severe disease
Data will support planned US and EU regulatory submissions for ruxolitinib cream in vitiligo in the second half of 2021
A new study commissioned by Clarins shows only 20% of men apply sun protection cream daily as per the minimum requirements.
Risankizumab (marketed as Skyrizi) can now be administered as one injection per dose, either by pre-filled pen or pre-filled syringe, to treat moderate to severe psoriasis in adults